Biomarkers and Biosimilars in Diabetes

Biosimilars are biological medical products/molecules which are almost identical copies of an original product manufactured by different companies and an already FDA-approved biological product, referred to as a reference product.  Human bio monitoring (HBM) is a tool of health-related environmental monitoring.

Diabetes is a major lifestyle disease, It is necessary to identify potential biomarkers associated with diabetes for early detection and proper management of diabetes.  Biomarkers are known as signature molecules or molecular markers or biological molecules found in blood, tissues and other body fluids. Biomarkers are used to monitor how well the body is responding to a particular disease. Hemoglobin A1c is considered as a biomarker for the presence of Diabetes Mellitus biosimilars in diabetes.

  • Scope and Role of Biomarkers
  • Biomarker Application in diabetes research
  • Novel Biomarkers
  • Biosimilar Development, Review, and Approval
  • Biosimilar and Interchangeable Products
  • Prescribing Biosimilar and Interchangeable Products
  • Biosimilar Product Information

Related Conference of Biomarkers and Biosimilars in Diabetes

November 28-29, 2022

International Conference on Diabetes & Heart Diseases

Yokohama, Japan
November 28-29, 2022

14th World Congress on Endocrinology and Metabolic Disorders

Amsterdam, Netherlands
January 30-31, 2023

6th Annual Meeting on Diabetes and Endocrinology

Barcelona, Spain
February 22-23, 2023

32nd European Diabetes Congress

Madrid, Spain
March 27-28, 2023

56th Annual Congress on Endocrinology & Disorders

Vancouver, Canada
April 18-19, 2023

Global Summit on Endocrinology

Madrid, Spain
April 18-19, 2023

European Endocrinology and Diabetes Congress

Madrid, Spain
May 15-16, 2023

4th Global summit on Diabetes and Endocrinology

Madrid, Spain
June 05-06, 2023

World Congress on Endocrine and Diabetes

San Francisco, USA
June 15-16, 2023

4th Annual conference on Diabetes

San Francisco, USA
July 24-25, 2023

19th International Conference on Diabetes & Care

Venice, Italy
August 10-11, 2023

25th World Congress on Diabetes and Endocrine Disorders

Dublin, Ireland
September 12-13, 2023

7th Annual Conference on Diabetes and Endocrinology

Barcelona, Spain
October 21-22, 2023

4th World Summit on Diabetes Expo

New York, USA

Biomarkers and Biosimilars in Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in